Health | Page 1114 of 1374 | SpiritIndia.com

Health Care :: Nursing Spectrum becomes Gannett Healthcare Group

Gannett Co., Inc. announced that Nursing Spectrum, a wholly owned subsidiary of Gannett since 1995 and the nation?s largest print and electronic publisher of information for registered nurses, is now Gannett Healthcare Group. The company?s 12 regional nursing publications will continue to operate under their existing brand names, Nursing Spectrum in the Eastern United States, and NurseWeek in the Western United States, as they have for nearly 20 years.

Health :: Highest Honor awarded to infectious disease experts from Harvard School of Public Health

Harvard School of Public Health (HSPH) has awarded its highest honor, for the promotion of high public health standards among vulnerable populations, to William H. Foege, former Director of the U.S. Centers for Disease Control and a founder of the Task Force for Child Survival and Development, and Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID). The two recipients have dedicated their lives to protecting people in this country and throughout the world from infectious diseases.

Ecology :: Stern Review on the Economics of Climate change

The most comprehensive review ever carried out on the economics of climate change was published today. The Review, which reports to the Prime Minister and Chancellor, was commissioned by the Chancellor in July last year. It has been carried out by Sir Nicholas Stern, Head of the Government Economic Service and former World Bank Chief Economist.

Asbestosis :: Government announces more money for asbestos sufferers

The Chief Secretary to the Treasury, Stephen Timms, and Secretary of State for Work and Pensions, John Hutton, announced that the Government will bring forward legislation to ensure that at least 800 sufferers of asbestos related diseases are able to keep their full compensation.

Nutrition :: Cognis launches 3 natural, non-GMO health ingredients at SupplySide West

Traffic at the Cognis Nutrition & Health booth at the SupplySide West trade show is expected to be brisk as dietary supplement and functional food manufacturers discover the benefits of three new, non-GMO natural health ingredients Cognis is launching — Covi-ox? T-95 EU natural mixed tocopherols, Vegapure? F40 WDP E water dispersible natural plant sterols, Xangold? 20% natural lutein ester beadlets.

Weight Loss :: Supplements help avoid ‘Weight Creep’ from Turkey and Sugar Plums – Tonalin CLA Study

CLA may serve critical role in preventing weight and fat gain during year-end holidays and with normal aging. Avoiding ‘weight creep’ from turkey and sugar plums is the theme of a consumer PR campaign Cognis Nutrition & Health is rolling out in time for the holiday season based on a Tonalin? CLA study recently published online in the prestigious International Journal of Obesity. The research suggests that Tonalin? CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.

Flu :: Cognis Targets Cold, Flu Season with Arsenal of Immunity-Enhancing Ingredients

A compromised immune system makes people more prone to contracting a cold or flu, and Cognis is helping companies meet the growing demand worldwide for immunity boosting dietary supplements and functional foods. Colds and flu are the most frequent infections across all age groups. Each year, Americans suffer from one billion colds, 100,000 are hospitalized and about 36,000 die from the flu and its complications. Immune health is also a global concern with frequent colds and flu ranked as one of the top three health problems by consumers in China, India and Latin America.

Nutrition :: Cognis to launch Omevital, omega-3 fatty acids at HiE

Cognis will unveil its new range of high quality omega-3 fish oil products at this year?s Health Ingredients Europe event in Frankfurt. Under the brand name Omevital?, and available in ethyl ester and triglyceride forms, the new range of marine-origin oils delivers products of outstanding quality and purity, ultra-refined through state-of-the-art manufacturing processes, in accordance with Pharma GMP standards.

Biofuel :: Broin and Novozymes to collaborate on development of ethanol from cellulosic biomass

Two leading players within the growing biofuels industry, Broin and Novozymes, announced a collaboration to take the next steps needed to bring cost-effective ethanol derived from corn stover to market. The collaboration is an extension of the close partnership between the two companies and is a great opportunity for Novozymes to put its unique biotechnology platform at work and for Broin to aim at a fast commercialization.

Alzheimer’s Disease :: Therapeutic approaches to Alzheimer’s Disease

Alzheimer’s disease is an age-related progressive neurodegenerative disorder with an enormous unmet medical need. It is the most common form of dementia affecting 5% of adults over 65 years. In view of our ageing society the number of patients, as well as the economical and social impact, is expected to grow dramatically in the future. Currently available medications appear to be able to produce moderate symptomatic benefits but not to stop disease progression.